The Week

Global X Uranium (URA.US) closed the week at $46.06, up 1.08% from the prior Friday’s close of $45.57. The S&P 500 added just 0.09% over the same period, leaving the ETF roughly 0.99 percentage points ahead of the benchmark. It was not a straight-line move: the fund opened Monday at $45.61, dipped to a weekly low of $43.55 on Tuesday, then climbed for three straight sessions to finish near the weekly high of $46.12. The 60-day range high sits at $50.09, about 8% above the latest close.

Sector News

The uranium and nuclear complex had a busy week, with small modular reactors (SMRs) and mine development dominating the flow. NuScale reported quarterly revenue of just $75,000 and announced a $750 million share sale, while also advancing ECCS component work with MillenniTEK — financing pressure and commercial progress in the same breath. The U.S. Army said it would spend $2.2 billion on micro nuclear reactors, a notable policy signal. On the mining side, NexGen featured heavily: its Rook I project was framed as potentially delivering up to 20% of global uranium supply, with first ore targeted for 2030 and around $1.3 billion in annual cash flow. Jefferies initiated Cameco and BWXT at buy, while Cantor Fitzgerald started Energy Fuels at buy. Oklo insiders kept selling, and the stock kept rising.

The Week Ahead

No URA constituents report earnings next week, but U.S. macro data is dense. On 10 September, initial jobless claims, final demand PPI and core PPI are due, feeding into rate expectations and valuation sentiment for rate-sensitive sectors. The 10-year Treasury auction on the same day also matters — the high yield and bid-to-cover ratio will signal how the market is pricing long-term rates. Beyond macro, the financing and project signals from uranium and SMR names this week will show whether they spread into broader sector sentiment.

In Short

A modestly positive week for URA.US coincided with an active news cycle, but the picture is mixed rather than one-sided. The Rook I supply narrative and the U.S. military’s micro-reactor push supported the upside, as did buy ratings on Cameco, BWXT and Energy Fuels. At the same time, NuScale’s thin revenue and large share sale, alongside steady insider selling at Oklo, highlighted the financing fragility behind high expectations. The latest session showed large-lot money as a net buyer, but that is a single-day snapshot, not a weekly trend. The question ahead is whether macro data unsettles rate-sensitive valuations, and whether SMR and uranium financing can keep pace with the narrative.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.